Taxpayers Against Fraud urged Congress to reject any attempts to weaken the federal False Claims Act or its whistleblower provisions in a report that tabulated a $1.25 billion federal gain from seven whistleblower lawsuits involving drugmakers. The lawsuits, which involved claims of criminal kickbacks to Medicaid rebate fraud, also netted $217 million for state treasuries and $188 million for whistleblowers, the group said. Sen. Chuck Grassley (R-Iowa), who co-wrote the modern False Claims Act, said the report underscores how effective the act as been as a weapon against healthcare fraud. Grassley called on lawmakers to revise a proposed regulation that would allow drug companies to destroy price data information after three years. -- by Mark Taylor
Group to Congress: Maintain strong False Claims Act
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.